文献速递肿瘤 PET/CT

经典霍奇金淋巴瘤二线治疗中期PET反应与一线治疗相当:支持统一疗效标准

Comparison of Interim PET Response to Second-Line Versus First-Line Treatment in Classic Hodgkin Lymphoma: Contribution to the Development of Response Criteria for Relapsed or Progressive Disease.
PubMed 文献 · J Nucl Med · 2020-08-06

该研究基于前瞻性多中心EuroNet-PHL-C1试验中127例复发经典霍奇金淋巴瘤患者,采用qPET方法回顾性定量分析一线与二线治疗早期反应。个体患者对两线治疗反应各异,但全体患者qPET值的经验累积分布函数几乎重叠,提示一线与二线治疗无需采用不同的PET疗效判断标准。

要点

  • 127例复发经典霍奇金淋巴瘤患者一线与二线治疗早期PET反应分布几乎重叠。
  • 个体患者对一线和二线治疗的反应存在差异,但群体水平反应分布一致。
  • 结果支持一线与二线治疗可沿用相同的PET疗效判断标准。

核心结论

  • 经典霍奇金淋巴瘤一线与二线治疗的早期PET反应标准无需区分,可沿用统一标准。

研究设计与样本

  • 对前瞻性多中心EuroNet-PHL-C1研究中127例复发经典霍奇金淋巴瘤患者进行一线与二线治疗早期反应的配对比较分析。
  • 采用qPET方法回顾性测量残留摄取,qPET为经过验证的Deauville评分半自动定量扩展方法。
  • 利用qPET值的经验累积分布函数系统分析一线与二线治疗的反应。

主要发现

  • 个体患者对一线与二线治疗的反应存在差异。
  • 全体患者一线与二线治疗qPET值的经验累积分布函数几乎重叠。

临床怎么用

  • 复发经典霍奇金淋巴瘤的二线治疗中期PET评估可参照一线治疗的Deauville评分标准进行判读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In first-line treatment of Hodgkin lymphoma (HL), Deauville scores 1-3 define complete metabolic remission. Interim 18F-FDG PET is also used for relapse-treatment adaptation; however, PET response criteria are not validated for relapse treatment. Methods: We performed a pairwise comparative analysis of early response to first- and second-line treatments in 127 patients with classic HL who experienced relapse. The patients participated in the prospective, multicenter EuroNet-PHL-C1 study. Residual uptake was measured retrospectively using the qPET method, a validated semiautomatic quantitative extension of the Deauville score. Empiric cumulative distribution functions of the qPET values were used to systematically analyze the response to first- and second-line treatments. Results: Individual patients responded variably to first- and second-line treatments. However, the empiric cumulative distribution functions of the qPET values from all patients were nearly superimposable. Conclusion: The findings support that first- and second-line treatments in HL do not require different response criteria.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Kluge R, Wittig T, Georgi TW, et al. Comparison of Interim PET Response to Second-Line Versus First-Line Treatment in Classic Hodgkin Lymphoma: Contribution to the Development of Response Criteria for Relapsed or Progressive Disease. J Nucl Med. 2020. PMID: 32764122. doi:10.2967/jnumed.120.247924

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。